MGMT and central nervous system cancer: Methylated DNA can have important implications and its analyses as biomarkers provides an additional tool for researchers and clinicians; for example, in gliomas, the most discussed epigenetic alteration is promoter hypermethylation of the gene for O6-methylguanine-DNA methyltransferase (MGMT) [12].